These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 5917906)

  • 1. New drugs and the Kefauver-Harris amendment.
    Krantz JC
    J New Drugs; 1966; 6(2):77-9. PubMed ID: 5917906
    [No Abstract]   [Full Text] [Related]  

  • 2. Progress under the Kefauver-Harris Drug Amendments.
    Rankin WB
    Pharmakotherapia; 1964; 2(1):215-22. PubMed ID: 5875717
    [No Abstract]   [Full Text] [Related]  

  • 3. New drugs: the AMA and the FDA.
    Appel JZ
    Ann Allergy; 1966 Jul; 24(7):333-6. PubMed ID: 5941864
    [No Abstract]   [Full Text] [Related]  

  • 4. The evolution of new drug legislation.
    Kelsey FO
    BMQ; 1966 Sep; 17(3):72-81. PubMed ID: 5978212
    [No Abstract]   [Full Text] [Related]  

  • 5. Government regulations and the use of drugs.
    Hafkenschiel JH
    Calif Med; 1967 Aug; 107(2):159-63. PubMed ID: 4862066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs of limited commercial value.
    Van Woert MH
    N Engl J Med; 1980 Jul; 303(2):114. PubMed ID: 7383068
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic equivalency of drugs. Fact or fiction?
    Stetler CJ
    Med Ann Dist Columbia; 1969 Jun; 38(6):297-300. PubMed ID: 5257886
    [No Abstract]   [Full Text] [Related]  

  • 8. Profitable and nonprofitable drugs.
    Van Woert MH
    N Engl J Med; 1978 Apr; 298(16):903-6. PubMed ID: 634333
    [No Abstract]   [Full Text] [Related]  

  • 9. The dermatologist, the cosmetic chemist, and the new law.
    Brauer EW
    J Med Soc N J; 1965 Oct; 62(10):489-91. PubMed ID: 5213164
    [No Abstract]   [Full Text] [Related]  

  • 10. RECENT EXPERIENCES WITH EFFECTIVE NEW DRUG APPLICATIONS.
    MEYERS EL
    Bull Parenter Drug Assoc; 1964; 18():1-6. PubMed ID: 14224959
    [No Abstract]   [Full Text] [Related]  

  • 11. THE PHYSICIAN AND THE FOOD AND DRUG ADMINISTRATION.
    SADUSK JF
    JAMA; 1964 Dec; 190():907-9. PubMed ID: 14214493
    [No Abstract]   [Full Text] [Related]  

  • 12. Human and veterinary drugs: good manufacturing practices and proposed exemptions for certain OTC products.
    Fed Regist; 1978 Sep; 43(190 Pt 2):45013-89. PubMed ID: 10316700
    [No Abstract]   [Full Text] [Related]  

  • 13. Issues in bringing new drugs to the market.
    Tracey WR
    Science; 2005 Dec; 310(5753):1425-6; author reply 1425-6. PubMed ID: 16329172
    [No Abstract]   [Full Text] [Related]  

  • 14. The food and Drug Administration's view of investigational drugs.
    MEYERS EL
    SD J Med Pharm; 1963 Jul; 16():40-6. PubMed ID: 13935340
    [No Abstract]   [Full Text] [Related]  

  • 15. A backward step in drug control.
    Feldman EG
    J Pharm Sci; 1966 Sep; 55(9):i. PubMed ID: 5918545
    [No Abstract]   [Full Text] [Related]  

  • 16. One decade of food and drug law scholarship: a selected bibliography.
    Noah L
    Food Drug Law J; 2000; 55(4):641-58. PubMed ID: 12025854
    [No Abstract]   [Full Text] [Related]  

  • 17. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CONTROL OF DRUG TOXICITY IN THE UNITED STATES OF AMERICA.
    WESTON JK; WESTON K
    Practitioner; 1965 Jan; 194():16-21. PubMed ID: 14259685
    [No Abstract]   [Full Text] [Related]  

  • 19. The Drug Abuse Control Amendments of 1965.
    R I Med J; 1966 Mar; 49(3):189 passim. PubMed ID: 5217555
    [No Abstract]   [Full Text] [Related]  

  • 20. Lawsuits anticipated on generic biologicals front.
    Fox JL
    Nat Biotechnol; 2003 Jul; 21(7):721-2. PubMed ID: 12833078
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.